Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY. (2023)
Attributed to:
OpenSAFELY, ISARIC, PHOSP: tracking consequences of COVID-19 infection across UK primary and secondary care.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjmed-2022-000276
PubMed Identifier: 36936265
Publication URI: http://europepmc.org/abstract/MED/36936265
Type: Journal Article/Review
Volume: 2
Parent Publication: BMJ medicine
Issue: 1
ISSN: 2754-0413